Discontinuation report LORAZEPAM INJECTION USP

Last updated on 2020-03-12 History
Report ID 106265
Drug Identification Number 02438704
Brand name LORAZEPAM INJECTION USP
Common or Proper name LORAZEPAM
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) LORAZEPAM
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1ml x 1 vial
ATC code N05BA
ATC description ANXIOLYTICS
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2020-02-14
Remaining supply date 2020-12-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments unforeseeable supply issue
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-03-12 French Compare
v5 2020-03-12 English Compare
v4 2020-02-15 French Compare
v3 2020-02-15 English Compare
v2 2020-02-14 English Compare
v1 2020-02-14 English Compare